For our in vivo tumor challenge, we used the TUBO cell line [25], a HER2+ cloned cell line established in vitro from a spontaneous mammary adenocarcinoma developed by a BALB/c-neuT mouse, which is transgenic for the rat HER2-neu oncogene [33]. This evidence concerns the gene ERBB2 and breast adenocarcinoma.